Onco-Hypertension in Patients with Kidney Disease

This article reviews available literature and proposes a step-by-step approach to manage cancer patients with concurrent hypertension and kidney disease.KEY MESSAGES: For antineoplastic medications with known hypertensive effect, blood pressure should be checked at baseline and serially during cancer treatment. Hypertensive crisis with end-organ damage, significant proteinuria, microscopic hematuria, or unexplained acute kidney injury necessitates drug cessation until further evaluation and resolution. In patients with chronic kidney disease and cancer therapy-related hypertension, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker is the preferred antihypertensive choice. Finally, multidisciplinary collaboration in these patients will yield the best results.PMID:38493776 | DOI:10.1159/000538375
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Source Type: research